Regulation of autoreactive CD4 T cells is essential to maintain selftolerance and prevent autoimmune disease. Although CD8 T regulatory (Treg) cells that recognize self-peptides restricted by Qa-1 (HLA-E in humans) inhibit autoreactive CD4 cells and attenuate experimental autoimmune encephalomyelitis (EAE), the mechanism of this interaction is unclear. We generated Qa-1 mutant knock-in mice that impair Qa-1 binding to the T cell receptor (TCR) and CD94/NKG2A receptors. Analysis of these mice showed that TCR-dependent recognition of Qa-1-peptide complexes on target CD4 cells is essential for suppression by CD8 Treg cells. Further analysis revealed that genetic disruption of the Qa-1-CD94/NKG2A interaction unleashes robust CD8 Treg cell activity that completely abolishes development of EAE.
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autoimmunity ͉ CD8 Treg ͉ suppression T here is considerable evidence that a regulatory sublineage of CD4 cells can inhibit the development of autoimmune disease in several murine models (1) . However, less attention has been given to the potential contribution of regulatory sublineages of CD8 cells to the prevention and treatment of autoimmunity. A subpopulation of CD8 cells that recognizes the MHC class Ib product Qa-1 (HLA-E in man) suppresses the development and relapse of experimental autoimmune encephalomyelitis (EAE) in a mouse model of multiple sclerosis (MS) (2, 3) , and mice lacking this CD8 subpopulation develop exaggerated immune responses to self-antigen (4) .
Analysis of Qa-1-deficient mice has not fully clarified the contribution of Qa-1 to immunologic suppression due to the ability of the Qa-1 molecule to interact with two distinct receptors. First, engagement of the T cell receptor (TCR) by Qa-1-peptide complexes can lead to activation and expansion of antigen-specific CD8 cells. Second, engagement of the CD94/NKG2A receptor expressed by CD8 cells and natural killer (NK) cells by Qa-1/Qdm peptide ligands attenuates the activities of these cells (5) (6) (7) . Thus, the immune response phenotype of Qa-1-deficient mice reflects these functionally distinct interactions. Diminished interactions between Qa-1-restricted CD8 cells and Qa-1-deficient CD4 cells results in enhanced CD4 responses, whereas increased NK cell lysis of activated CD4 cells reflects a loss of the inhibitory NKG2A-Qa-1/Qdm interaction.
We isolated Qa-1-dependent engagement of the TCR and NKG2A for analysis and exploited the fact that Qa-1-dependent binding to each receptor used distinct Qa-1 contact residues. We thus generated knock-in mice that express a Qa-1 amino acid exchange mutation (Qa-1 D227K) that disrupts binding of Qa-1 to the CD8 coreceptor (8) . Cells that express this Qa-1 D227K point mutation fail to present Qa-1-restricted peptides to CD8 cells but retain the ability to engage NKG2A receptors on CD8 cells and NK cells. A second Qa-1 knock-in strain (Qa-1 R72A) expresses a Qa-1 aa exchange mutation (R72A) that fails to bind to NKG2A receptors on NK cells and CD8 cells but spares Qa-1-dependent peptide presentation to the TCR (7). Expression of this Qa-1 aa exchange mutant by CD4 cells renders them vulnerable to NK and CD8 lysis. These two Qa-1 point mutations were backcrossed to C57BL/6 mice for analysis of CD8 T regulatory (Treg) cell activity.
We report that engagement of Qa-1 by the CD8 coreceptor is essential for Qa-1-restricted Treg activity, as indicated by findings that Qa-1 D227K knock-in mice fail to develop regulatory CD8 activity and display enhanced proteolipid protein (PLP)-induced EAE. Analysis of Qa-1 R72A knock-in mice revealed that genetic disruption of the NKG2A-Qa-1 interaction releases the brakes on CD8-dependent suppressive activity, allowing the development of robust CD8 ϩ Treg activity, which results in complete resistance to the development of EAE.
Results and Discussion
Analysis of B6.Qa-1 D227K and R72A Knock-In Mice. A genomic 4-Kb Qa-1 fragment containing a D 3 K amino acid exchange mutation at position 227 after site-directed mutagenesis (Fig. 1A ) was cloned into a replacement vector and transfected into the TC1 ES cell line. After injection of positive homologous recombinant clones into blastocysts to produce germline chimeras (Fig. 1B) , and deletion of the Neo r gene after crossing to B6-EII␣-CRE mice, progeny were backcrossed to C57BL/6 (B6) for seven generations and intercrossed to produce homozygous B6.Qa-1 D227K mutant mice. Expression of cell surface Qa-1 by activated (ConA-stimulated) CD4 cells from B6.Qa-1 D227K knock-in mice was indistinguishable from Qa-1 WT T cells (Fig. 1C) . Expression of the Qa-1 D227K mutation by L cells (Fig. 1D , Left) or activated CD4 cells (Fig. 1D , Right) failed to target these cells for lysis by Qa-1-restricted cytolytic T cells (CTLs). Qa-1/Qdm-dependent resistance of activated B6.Qa-1 D227K CD4 cells to lysis by NKG2A ϩ NK cells was unimpaired in vitro (Fig. 1E , Left) and in vivo, as judged by homeostatic expansion in Rag-2 Ϫ/Ϫ hosts (Fig. 1E, Right) .
Cells from B6 Qa-1 knock-in mice that expressed the Qa-1 R72A mutation were unable to bind to NKG2A and, as a consequence, displayed increased susceptibility to NK lysis in vitro (Fig. 1E , Left) and failed to expand in Rag-2 Ϫ/Ϫ hosts in vivo (Fig. 1E, Right) . Taken together, these observations indicate that the interaction of Qa-1 with the TCR-CD8 complex can be experimentally separated from its interaction with NKG2A using B6.Qa-1 D227K and B6.Qa-1 R72A knock-in mice.
We next monitored the effect of the Qa-1 D227K point mutation on the inhibitory interaction between CD8 Treg cells and CD4 Th cells (4) . CD8 cells obtained from B6 mice immunized with irradiated activated OT-2 CD4 T cells 2 weeks earlier were transferred along with OT-2 CD4 cells into Rag2 Ϫ/Ϫ Prf1 Ϫ/Ϫ hosts immunized with OT-2 peptide. Expansion of Qa-1 WT and Qa-1 R72A OT2 ϩ CD4 cells was substantially inhibited by CD8 cells, whereas expansion of D227K OT-2 cells was unimpaired (Fig. 1F) . These findings indicate that the Qa-1-restricted suppressive inter-action between CD8 and CD4 cells requires CD8 coreceptor binding to the Qa-1 molecule on CD4 cells, but not binding to the NKG2A receptor.
Enhanced Susceptibility of Qa-1 D227K Knock-In Mice to EAE. As noted previously (4), preimmunization of mice with myelin oligodendrocyte glycoprotein (MOG) peptide before induction of EAE with MOG/complete Freund's adjuvant (CFA) and pertussis toxin induces CD8
ϩ Treg cells, which inhibit the development of EAE ( Fig.  2A) . In contrast, preimmunization of B6.Qa-1 D227K mice with MOG peptide is followed by robust disease development (Fig. 2 A) . Moreover, CD4 cells from B6.Qa-1 D227K mice, but not from B6 control littermates, mediate vigorous anti-MOG recall responses, as indicated by production of the IFN-␥ and IL-17 proinflammatory cytokines (Fig. 2B) . Enhanced IFN-␥/IL-17 responses were not accompanied by diminished levels of inhibitory cytokines, including IL-10 and IL-4, which were not detectable in these supernatants (not shown).
We then investigated whether the Qa-1 D227K mutation prevented the development of CD8 Treg cells to a second self-antigen, PLP. Preimmunization of B6 mice with PLP peptide (without pertussis toxin) induces PLP-specific CD8 ϩ Treg cells, which inhibit EAE on a subsequent challenge with PLP/CFA and pertussis toxin (4) . In contrast, preimmunization of B6.Qa-1 D227K littermates with PLP/CFA failed to prevent the development of severe EAE on challenge with PLP/CFA plus pertussis toxin (Fig. 2C) . Loss of protection by Qa-1 D227K knock-in mice was associated with substantially increased anti-PLP IFN-␥ responses by CD4 cells on challenge with PLP (Fig. 2D) . In summary, expression of the Qa-1 D227K point mutation that prevents Qa-1-restricted recognition by CD8 cells results in markedly enhanced CD4 response to PLP self-antigens and the consequent development of EAE.
Suppression by CD8 ؉ Treg Cells Is Attenuated by Engagement of NKG2A. In contrast to B6 mice, which express the Qa-1 D227K mutation, B6.Qa-1 R72A knock-in mice were completely protected from induction of EAE by preimmunization with PLP. Protection was accompanied by markedly reduced anti-PLP IFN-␥ responses on restimulation of CD4 cells in vitro (Fig. 2D) , suggesting that engagement of Qa-1/Qdm on CD4 cells by NKG2A on CD8 Treg cells impairs their suppressive activity. Homeostatic expansion of Qa-1 mutant CD4 cells. A total of 10 6 CD4 ϩ T cells isolated from Qa-1 WT, Qa-1-deficient, Qa-1 D227K, and Qa-1 R72A mice were transferred into syngeneic Rag2 Ϫ/Ϫ hosts. Fourteen days later, CD4 ϩ T cells from spleen and lymph nodes were enumerated. Data, shown as mean Ϯ SD, represent one of two independent experiments (n ϭ 3). (F) CD4 T cells from OT-2 TCR-transgenic B6 mice activated with ConA were used to vaccinate B6 mice. Fourteen days later, purified CD8 T cells (1.5 ϫ10 6 ) from OT-2-immunized mice were transferred with OT-2 CD4 T cells (from Qa-1 WT, Qa-1 Ϫ/Ϫ , Qa-1 D227K, and Qa-1 R72A; 1 ϫ 10 6 ) into Rag2 Ϫ/Ϫ Prf1 Ϫ/Ϫ mice before challenge with OVA peptide (50 g) in CFA. Expansion of OT-2 T cells was quantitated by enumerating OT-2 cells in both lymph nodes and spleen 2 weeks after transfer. Data are representative of two independent experiments (n ϭ 3).
To directly test this hypothesis, we investigated the susceptibility of MOG-immune CD4 cells expressing the R72A mutation to Qa-1-restricted inhibition by CD8
ϩ Treg cells in adoptive Rag2
hosts. Because activated CD4 T cells that fail to engage inhibitory NKG2A receptors on NK cells are also susceptible to NK cell lysis (7), we eliminated NK activity using adoptive Rag2 Ϫ/Ϫ Prf1 Ϫ/Ϫ hosts. Cotransfer of CD8 cells with MOG-immune Qa-1 WT CD4 cells into Rag2 Ϫ/Ϫ Prf1 Ϫ/Ϫ hosts resulted in modest inhibition of EAE (Fig. 3A , Left). In contrast, transfer of EAE by MOG-immune CD4 cells from R72A donors was completely abolished by cotransfer of CD8 cells, despite the fact that R72A CD4 cells alone induced EAE levels that were at least as robust as those induced by CD4 cells from Qa-1 WT littermate donors (Fig. 3B, Left) . Analysis of the in vitro recall response to MOG at 3 weeks revealed that cotransfer of CD8 cells with R72A CD4 cells virtually abolished the anti-MOG recall response, as indicated by IFN-␥ secretion ( Fig. 3A and B, Right) .
A more stringent test of the affect of the Qa-1 R72A mutation on the susceptibility of CD4 cells to CD8 Treg cell activity was based on an analysis of the ability of CD8 cells to inhibit CD4 cells that express the MOG-specific 2D2 TCR transgene. Transfer of 2D2 ϩ CD4 cells into Rag2 Ϫ/Ϫ Prf1 Ϫ/Ϫ hosts initiates a progressive and lethal form of EAE that results in death from fulminant disease within 14-16 days after transfer (Fig. 3C) . If CD8-dependent suppression of 2D2 ϩ CD4 cells is normally attenuated by an inhibitory interaction between Qa-1/Qdm expressed by CD4 target cells and NKG2A receptors expressed by CD8 Treg cells, then genetic disruption of this interaction might be expected to suppress virulent EAE. Transfer of 10 6 2D2 ϩ CD4 cells (five times the lethal dose) from B6 or B6 Qa-1 R72A donors into Rag2 Ϫ/Ϫ Prf1 Ϫ/Ϫ hosts provoked lethal EAE by day 15 (Fig. 3C, Left) ; however, cotransfer of CD8 ϩ Treg cells completely abrogated disease induced by R72A CD4 cells, whereas cotransfer of CD8 ϩ Treg cells had no effect on Qa-1 WT CD4 cells (Fig. 3C, Right) .
We next determined whether abolition of EAE development by cotransfer of CD8 cells was associated with suppression of 2D2 ϩ CD4 T cell expansion in Rag2 Ϫ/Ϫ Prf1 Ϫ/Ϫ hosts. Expansion of R72A 2D2 CD4 T cells was almost completely (Ͼ 95%) suppressed by cotransfer of CD8 cells, whereas expansion of Qa-1 WT 2D2 CD4 T cells was reduced only slightly by MOG-immune CD8 T cells (Fig.  3D ). Moreover, a residual amount (5%) of Qa-1 R72A 2D2 ϩ CD4 cells displayed almost no response to MOG in vitro (Fig. 3E) . Thus, failure of EAE development is attributed to CD8-dependent suppression of the anti-MOG response of 2D2 ϩ CD4 cells bearing the MOG-specific TCR.
Interruption of the Qa-1-NKG2A Interaction Unmasks Potent CD8 ؉ Treg Cell Activity In Vitro. The analysis summarized in Fig. 3 suggests that CD4 T cells expressing a Qa-1 point mutation that impairs engagement of NKG2A expressed by CD8
ϩ Treg cells releases the brakes on suppressive activity inflicted by CD8 ϩ Treg cells. Analysis of the interaction between Qa-1 R72A mutant CD4 cells and CD8 Treg cells in vitro revealed that the MOG-specific response of Qa-1 R72A 2D2 ϩ CD4 T cells was highly susceptible to dose-dependent suppression by CD8 Treg cells in vitro, as indicated by diminished proliferation and IL-2 secretion. In contrast, CD4 cells bearing the Qa-1 D227K mutation were fully resistant to CD8 Treg cell activity (Fig. 4A) . The dependence of CD8 Treg cell activity on Qa-1 recognition was confirmed by the finding that anti-Qa-1 Ab blocked CD8-dependent suppression of the CD4 cell IL-2 response (Fig. 4B) .
Perforin Expression Contributes to Suppressive Activity. We tested the contribution of perforin and Fas ligand to Treg-mediated suppression. CD8 T cells from immunized perforin-deficient (Prf1 Ϫ/Ϫ ) or Fas ligand-deficient generalized lymphoproliferative disease (FasL Ϫ/Ϫ ) mice were cotransferred with Qa-1 R72A 2D2 CD4 T cells. Expansion of R72A 2D2 CD4 T cells was inhibited by FasL Ϫ/Ϫ CD8 cells but not by Prf1 Ϫ/Ϫ CD8 cells. The requirement for perforin (but not Fas ligand) for CD8 ϩ Treg cell activity also was noted in vitro. CD8 T cells from immunized Prf1 Ϫ/Ϫ mice were unable to inhibit the response of R72A 2D2 ϩ CD4 cells, in contrast to CD8 T cells from FasL Ϫ/Ϫ mice (Fig. 5B ). Although Qa-1 R72A CD4 cells may be lysed by CD8 cells from immunized mice (Fig. 5C ), these observations do not rule out a nonlytic mechanism of suppression. Indeed, a cardinal feature of ''suppressed'' CD4 cells is their failure to express effector (Th1) cytokines, including IFN-␥, on stimulation with antigen. Although the regulatory lineage of CD4 ϩ T cells has been the object of intense study, regulatory cells within the CD8 ϩ lineage have received much less attention. Analyses of normal and Qa-1-deficient mice have defined a subpopulation of CD8 cells that mediate Treg activity through recognition of the class Ib MHC molecule Qa-1 expressed on activated CD4 cells. The interactions between CD8 ϩ Treg cells and target CD4 cells that regulate this process are not well understood, however. The present study establishes that this inhibitory interaction requires CD8 corecognition of peptides complexed to the Qa-1 MHC molecule expressed by activated target CD4 cells. These findings also provide new insight into the molecular constraints that dampen CD8 ϩ Treg cell activity.
We find that Qa-1/Qdm engagement of CD94/NKG2A on CD8 ϩ Treg cells transmits an inhibitory signal that attenuates CD8 Treg suppressive activity. The CD94/NKG2A receptors belong to the inhibitory NK receptor family (iNKRs) that inhibits cellular activation through dephosphorylation of signaling molecules. Although the CD94 chain can pair with other members of the NKG2 family, including NKG2C and NKG2E (9), the high levels of expression and strong binding affinity of CD94/NKG2A for Qa-1/Qdm dominate binding. As a result, engagement of CD94/NKG2A receptors expressed by activated CD8 cells during viral infection downregulates cytotoxicity and production of proinflammatory cytokines (6, 10) . Although only a small proportion of CD8 cells express NKG2A according to immunofluorescence with available antibodies, most CD8 cells specifically bind Qa-1/Qdm tetramers and this may account for the substantial affect of NKG2A ligation (10) .
Autoreactive CD4 cells that express the Qa-1 R72A point mutation fail to transmit an inhibitory signal through NKG2A to CD8 ϩ Treg cells. As a result, these CD4 cells received maximal inhibitory signals from CD8 Treg cells and failed to induce EAE. These findings suggest that releasing the brakes on CD8 Treg activity by blockade of NKG2A with Ab may represent a new CD8 ϩ Treg-based approach to ameliorating autoimmune disease.
The timing of CD8 ϩ -dependent inhibitory responses can be contrasted with that of naturally occurring CD4 ϩ CD25 ϩ Treg cells, which interrupt expansion of self-reactive T cells during the initial stages of primary responses. Regulatory CD8 ϩ T cells arise later in the immune response and become apparent experimentally only after restimulation by antigen (11) . The development of Qa-1-restricted Treg activity more closely resembles the kinetics of CD8 ϩ -dependent memory/effector activity rather than CD4 ϩ CD25 ϩ regulatory activity. CD8 ϩ -dependent suppressive and memory/effector responses both require primary immunization to generate TCR-dependent lysis or Qa-1-restricted inhibition of target cells (4, 12). (10 6 ) enriched from Qa-1 WT and R72A 2D2 TCR-transgenic mice were transferred into syngeneic Rag2 Ϫ/ϪPrf1Ϫ/Ϫ hosts (n ϭ 5) with or without CD8 Treg cells generated as described in Methods. Hosts were then immunized with 10 g of MOG/CFA and 200 g of pertussis toxin (on days 0 and 2). Development of EAE was scored daily as described in Methods. (D) In vivo suppression of R72A 2D2 expansion by CD8 regulatory cells. 2D2 CD4 ϩ T cells (10 6 ) from Qa-1 WT or R72A mice were transferred into syngeneic Rag2 Ϫ/Ϫ Prf1 Ϫ/Ϫ hosts (n ϭ 3) with or without CD8 Treg cells generated as described in Methods. Hosts were then immunized with 10 g of MOG/CFA. 2D2 CD4 T cells in the draining lymph nodes and spleens were enumerated after 14 days. Data are shown as mean Ϯ SD (n ϭ 3). (E) Single-cell suspensions were prepared from draining lymph nodes collected as described above and pooled according to each group. The lymph node cells were stimulated with the indicated concentrations of MOG peptide in the presence of irradiated splenocytes as antigen-presenting cells. IL-2 secretion was measured by ELISA 48 h after culture.
These data also suggest that the relative ratio of the two classes of Qa-1 peptide ligand-Qdm peptide versus non-Qdm (e.g., HSP60) peptide-on the surface of activated CD4 cells may determine the susceptibility of these CD4 ϩ T cells to suppression by CD8 ϩ Treg cells. According to this view, engagement of NKG2A on CD8
ϩ Treg cells by the Qdm/Qa-1 ligand on target CD4 cells inhibits Treg activity, whereas engagement of the TCR expressed by CD8
ϩ Treg cells by Qa-1 peptide ligands, such as HSP60 peptides (13), activates suppressive activity. Because the majority of murine CD8 ϩ T cells bind to Qa-1/Qdm tetramer, differential expression of Qa-1/Qdm and Qa-1/HSP60 peptide ligands on activated Qa-1 CD4 target cells may determine the cell's fate.
Although MS is characterized by a clinical sequence of exacerbations followed by remissions, the clinical course is generally progressive. Analysis of disease in a murine model of MS (i.e., EAE) has begun to define the immunologic mechanisms responsible for this process. Immunologic susceptibility to disease and disease remission depends in part on inhibition of pathogenic autoreactive CD4 T cells by CD8
ϩ Treg cells, resulting in decreased tissue destruction and inhibition of disease progression (4, 7, 14, 15) . These findings provide the basis for development of new therapeutic approaches to autoimmune diseases, including MS. Although current approaches have generated CD8 ϩ Treg cell activity before disease induction (16, 17) , these cells are not potent enough to shut down disease progression.
Recent analysis of T cells from MS patients also indicates that CD94/NKG2A inhibitory receptors expressed by CD8 Treg cells restrain their HLA-E-restricted suppressive activity, and that these HLA-E-restricted CD8 Treg cells cloned from patients during disease exacerbation express higher levels of CD94/NKG2A compared with CD8 cells cloned from MS patients in remission or CD8 cells obtained from healthy controls (18) . Moreover, Ab-dependent blockade of the HLA-E-CD94/NKG2A interaction enhances lysis of autoreactive CD4 T cell clones by HLA-E-restricted CD8 cells from MS patients (18) , consistent with our findings using a murine model of MS. Additional studies are currently underway using combination therapy of CD8 ϩ Treg cells with blocking anti-NKG2A Ab to treat ongoing MOG-induced EAE in B6 mice, in an effort to increase the therapeutic potential of this approach to MS.
Methods
Animals and Reagents. C57BL/6 (B6) and Rag2 Ϫ/Ϫ Prf1 Ϫ/Ϫ (perforin) mice were purchased from Taconic. Qa-1 D227K and Qa-1 R72A mice were generated as described previously and backcrossed onto B6 for eight generations. OT-2 TCRtransgenic mice (provided by H. Ploegh, MIT) and 2D2 TCR-transgenic mice that recognize the MOG autoantigen (19) were crossed with Qa-1 D227K and Qa-1 R72A mice. Mice were housed in a specific pathogen-free, viral Ab-free animal facility at the Dana-Farber Cancer Institute. All experiments were done in compliance with federal laws and institutional guidelines and were approved by the DFCI Animal Care and Use Committee.
Peptides MOG 35-55 (MEVGWYRSPFSRVVHLYRNGK), OVA 323-339 (ISQAVHAA-HAEINEAGR), and PLP 172-183 (PVYIYFNTWTTC) were synthesized by New England Peptide. Mouse CD4 and CD8 T lymphocyte enrichment kits, ELISA kits for cytokines, and other purified antibodies were purchased from BD Biosciences.
Generation of Qa-1 Mutant Knock-In Mice.
A BAC clone containing a 11-kb DNA fragment including the Qa-1 gene was identified and fully mapped. A 4-kb fragment containing exons 1-5 of Qa-1 (from NdeI to AvrII) was cloned into a cloning vector, and the mutation of D227 to K was introduced by site-directed mutagenesis. After confirmation by sequencing, the mutated DNA fragment was cloned into the SalI site of pLNTK (20) . The 2.3-kb short arm (AvrII to NdeI) was cloned into the XhoI site of pLNTK to complete the replacement vector. The targeting vector was linearized by NotI and used for ES cell electroporation. After TC1 ES cells were transfected with targeting vector, positively selected recombinants were identified by long-range PCR screening and Southern blot analysis. The Neo r gene was deleted by crossing germline-transmitted litters to EII␣-CRE mice, followed by backcrossing to B6 mice for eight generations. Homozygous Qa-1-D227K mutant mice were obtained by intercrossing heterozygous littermates.
NK Cell Purification and NK Cytotoxic Assay. To purify NKG2A ϩ NK cells, splenocytes from Rag2 Ϫ/Ϫ mice were incubated with biotinylated NKG2AB6 mAb (eBioscience), followed by incubation with antibiotin Ab-coated magnetic microbeads (Mytech) before cell separation using magnetic-activated cell sorting. Purified NKG2A ϩ NK cells were cultured in RPMI 1640 complete medium with 10% FCS and 1000 U/ml of human recombinant IL-2 (BD Biosciences) for 5 days. Then 10 6 target cells were labeled with 100 Ci of Na2( 51 Cr)O4 for 1 h at 37°C. After three washes with PBS, 10 4 target cells were mixed with NK cells at different E:T ratios and incubated for 4 h. Cell-free supernatants were collected, and their radioactivity was measured with a Wallac Microbeta counter. The percentage of lysis was calculated by the following formula: (sample release Ϫ spontaneous release)/(maximum release Ϫ spontaneous release) ϫ 100%. Generation of CD8 Suppressor Cells and In Vivo Suppression Assay. CD4 T cells were purified and activated in vitro by ConA (1 g/ml) or peptide antigen for 2 days before irradiation (3,000 rads) and injection into B6 mice (2 ϫ 10 6 cells i.v.). After 14 days, CD8 T cells purified from the spleen were adoptively transferred into Rag2 Ϫ/Ϫ Prf1 Ϫ/Ϫ mice along with purified target CD4 T cells. Adoptive hosts were challenged with antigen peptide (50 g) in CFA, and the expansion of CD4 T cells and CD8 cells was analyzed 14 days later. CD8 ϩ Treg cells also were generated after injection of 10 6 2D2 ϩ TCR-transgenic CD4 cells i.v. into B6 mice, followed by immunization with 50 g of MOG peptide to activate and expand 2D2 cells. CD8 cells were purified 14 days later from both draining lymph nodes and spleen and tested for suppressive activity against 2D2 CD4 T cells in Rag2 Ϫ/Ϫ Prf1 Ϫ/Ϫ hosts, as described above. CD8 cells expressing suppressive activity against polyclonal MOG-reactive CD4 T cells were purified from draining lymph nodes of MOG-induced EAE mice. 
Generation of CTLs and In Vitro Lysis.
To generate anti Qa-1 alloreactive CTLs, CD4 T cells were purified from B6 mice and activated in vitro by ConA (1 g/ml) for 2 days before irradiation (3,000 rads) and injection into B6.Tla mice (2 ϫ10 6 cells i.v.). Fourteen days later, 5 ϫ 10 6 purified CD8 T cells from spleen were restimulated in vitro with 10 7 irradiated ConA-activated B6 lymphocytes with 20 U/ml of IL-2 in RPMI 1640 complete medium, 10% FCS, and 50 M ␤-mercaptoethanol. Cytotoxic activity was measured after 5 days of culture. First, 10 6 target cells in 100 l of RPMI 1640 complete medium were labeled with 100 Ci of Na2( 51 Cr)O4 for 1 h at 37°C and washed three times with PBS. After resuspension in RPMI 1640 complete medium, 10 4 labeled target cells were mixed with effector cells at different E:T ratios (5:1, 10:1, and 20:1) in triplicate and then incubated for 4 h at 37°C. Cell-free supernatants were collected, and their radioactivity was measured with a Wallac Microbeta counter. The percentage of lysis was calculated by the following formula: (sample release Ϫ spontaneous release)/ (maximum release Ϫ spontaneous release) ϫ100%. 
